Skip to main content
Addgene

pCMV-AD-uvr8at
(Plasmid #44971)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 44971 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pCMV-AD
  • Backbone manufacturer
    Stratagene
  • Backbone size w/o insert (bp) 3555
  • Total vector size (bp) 5484
  • Vector type
    Mammalian Expression

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    AD-UVR8
  • Alt name
    UV-B resistance 8
  • Species
    A. thaliana (mustard weed)
  • Insert Size (bp)
    1929
  • Mutation
    deleted Methionine 1
  • GenBank ID
    NM_125781.3
  • Entrez Gene
    UVR8 (a.k.a. AT5G63860, MGI19.7, MGI19_7, UVB-RESISTANCE 8)
  • Promoter pCMV
  • Tag / Fusion Protein
    • NF-κB activation domain (N terminal on insert)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site BamHI (not destroyed)
  • 3′ cloning site NotI (not destroyed)
  • 5′ sequencing primer CMV Forward
  • 3′ sequencing primer T7
  • (Common Sequencing Primers)

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pCMV-AD-uvr8at was a gift from Thanos Halazonetis (Addgene plasmid # 44971 ; http://n2t.net/addgene:44971 ; RRID:Addgene_44971)
  • For your References section:

    Ultraviolet-B-mediated induction of protein-protein interactions in mammalian cells. Crefcoeur RP, Yin R, Ulm R, Halazonetis TD. Nat Commun. 2013;4:1779. doi: 10.1038/ncomms2800. 10.1038/ncomms2800 PubMed 23653191